We found that in the Prognoscan data set, multiple cancers showed a marked correlation between the prognosis of patients and the expression level of MYL9 including lung, ovarian, blood, prostate, brain, breast, and colorectal cancer (Figure 2A–L). Here, MYL9 is linked to colorectal cancer.